{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:30:46Z","timestamp":1778815846539,"version":"3.51.4"},"reference-count":33,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tissue factor pathway inhibitor (TFPI) is a serine protease with multiple anticoagulant activities. The Kunitz1 (K1) domain of TFPI binds the active site of factor VIIa and is required for inhibition of tissue factor (TF)\/factor VIIa catalytic activity. Mice lacking TFPI K1 domain die in utero. TFPI is highly expressed on trophoblast cells of the placenta. We used genetic strategies to selectively ablate exon 4 encoding TFPI K1 domain in the embryo, while maintaining expression in trophoblast cells. This approach resulted in expected Mendelian frequency of TFPI K1 domain\u2013deficient mice. Real-time polymerase chain reaction confirmed 95% to 99% genetic deletion and a similar reduction in transcript expression. Western blotting confirmed the presence of a truncated protein instead of full-length TFPI. Mice with severe TFPI K1 deficiency exhibited elevated thrombin-antithrombin (TAT) levels, frequent fibrin deposition in renal medulla, and increased susceptibility to TF-induced pulmonary embolism. They were fertile, and most lived normal life spans without any overt thrombotic events. Of 43 mice observed, 2 displayed extensive brain ischemia and infarction. We conclude that in contrast to complete absence of TFPI K1 domain, severe deficiency is compatible with in utero development, adult survival, and reproductive functions in mice. Inhibition of TFPI activity is being evaluated as a means of boosting thrombin generation in hemophilia patients. Our results show that in mice severe reduction of TFPI K1 activity is associated with a prothrombotic state without overt developmental outcomes. We note fibrin deposits in the kidney and rare cases of brain ischemia.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018018853","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T21:45:36Z","timestamp":1550007936000},"page":"489-498","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency"],"prefix":"10.1182","volume":"3","author":[{"given":"Michelle M.","family":"Castillo","sequence":"first","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology,"},{"name":"Department of Cell Biology, Neurobiology and Anatomy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhui","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Y.","family":"Pan","sequence":"additional","affiliation":[{"name":"Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Neurobiology and Anatomy, and"},{"name":"Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Sood","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pathology, Department of Pathology,"},{"name":"Department of Cell Biology, Neurobiology and Anatomy, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"issue":"1","key":"2020021108333559600_B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/ATVBAHA.115.305996","article-title":"Tissue factor pathway inhibitor: multiple anticoagulant activities for a single protein","volume":"36","author":"Mast","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2020021108333559600_B2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-3782(00)00084-0","article-title":"Expression of tissue factor pathway inhibitor in human fetal and placental tissues","volume":"59","author":"Edstrom","year":"2000","journal-title":"Early Hum Dev"},{"issue":"12","key":"2020021108333559600_B3","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.ATV.0000042456.84190.F0","article-title":"Characterization of the association of tissue factor pathway inhibitor with human placenta","volume":"22","author":"Mast","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2020021108333559600_B4","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2005-10-4111","article-title":"Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells","volume":"107","author":"Sood","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2020021108333559600_B5","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1538-7836.2009.03454.x","article-title":"Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice","volume":"7","author":"Maroney","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"6215","key":"2020021108333559600_B6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor","volume":"338","author":"Girard","year":"1989","journal-title":"Nature"},{"issue":"8","key":"2020021108333559600_B7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2009-10-246686","article-title":"The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition","volume":"116","author":"Ndonwi","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2020021108333559600_B8","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"2020021108333559600_B9","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"2020021108333559600_B10","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1182\/bloodadvances.2017011098","article-title":"TFPI\u03b1 interacts with FVa and FXa to inhibit prothrombinase during the initiation of coagulation","volume":"1","author":"Wood","year":"2017","journal-title":"Blood Adv"},{"issue":"8","key":"2020021108333559600_B11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1538-7836.2008.03033.x","article-title":"Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans","volume":"6","author":"Maroney","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2020021108333559600_B12","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2008-06-162453","article-title":"Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency","volume":"112","author":"Duckers","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2020021108333559600_B13","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/hae.12280","article-title":"Acquired factor V deficiency in a patient without evidence of a classical inhibitor","volume":"20","author":"Sosa","year":"2014","journal-title":"Haemophilia"},{"issue":"2","key":"2020021108333559600_B14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V78.2.387.387","article-title":"Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"issue":"3","key":"2020021108333559600_B15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V90.3.944.944_944_951","article-title":"Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"issue":"7","key":"2020021108333559600_B16","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2004-09-3724","article-title":"A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice","volume":"105","author":"Pedersen","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2020021108333559600_B17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood-2009-10-250910","article-title":"Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis","volume":"116","author":"White","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2020021108333559600_B18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2","article-title":"Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function","volume":"26","author":"Tallquist","year":"2000","journal-title":"Genesis"},{"issue":"6851","key":"2020021108333559600_B19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/35092573","article-title":"Role of thrombin signalling in platelets in haemostasis and thrombosis","volume":"413","author":"Sambrano","year":"2001","journal-title":"Nature"},{"issue":"11","key":"2020021108333559600_B20","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2012-08-448209","article-title":"Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model","volume":"121","author":"An","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2020021108333559600_B21","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1182\/blood-2002-05-1470","article-title":"Protection against thrombosis in mice lacking PAR3","volume":"100","author":"Weiss","year":"2002","journal-title":"Blood"},{"issue":"15","key":"2020021108333559600_B22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/bloodadvances.2017005058","article-title":"Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation","volume":"1","author":"van Mens","year":"2017","journal-title":"Blood Adv"},{"issue":"26","key":"2020021108333559600_B23","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood-2015-03-633958","article-title":"A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development","volume":"125","author":"Ellery","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2020021108333559600_B24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI5678","article-title":"Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit","volume":"103","author":"Chan","year":"1999","journal-title":"J Clin Invest"},{"issue":"6","key":"2020021108333559600_B25","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/bloodadvances.2016002295","article-title":"Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state","volume":"1","author":"Wood","year":"2017","journal-title":"Blood Adv"},{"issue":"8","key":"2020021108333559600_B26","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1182\/blood-2005-01-0406","article-title":"Extraembryonic expression of EPCR is essential for embryonic viability","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2020021108333559600_B27","first-page":"462","article-title":"Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge","volume":"88","author":"Castellino","year":"2002","journal-title":"Thromb Haemost"},{"issue":"5","key":"2020021108333559600_B28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00001721-199507000-00004","article-title":"Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A","volume":"6","author":"Erhardtsen","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"2020021108333559600_B29","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.thromres.2012.08.299","article-title":"Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia","volume":"130","author":"Gissel","year":"2012","journal-title":"Thromb Res"},{"issue":"10","key":"2020021108333559600_B30","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1073\/pnas.1119858109","article-title":"Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia","volume":"109","author":"Maroney","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2020021108333559600_B31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1074\/jbc.M113.533836","article-title":"Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI)","volume":"289","author":"Dockal","year":"2014","journal-title":"J Biol Chem"},{"issue":"7528","key":"2020021108333559600_B32","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1038\/515S168a","article-title":"Thrombosis: Balancing act","volume":"515","author":"Willyard","year":"2014","journal-title":"Nature"},{"issue":"5","key":"2020021108333559600_B33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/jth.12864","article-title":"Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial","volume":"13","author":"Chowdary","year":"2015","journal-title":"J Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/3\/489\/1630875\/advances018853.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/3\/3\/489\/1630875\/advances018853.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T14:02:16Z","timestamp":1581429736000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/3\/3\/489\/246741\/Maintaining-extraembryonic-expression-allows"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018018853","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,12]]}}}